Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis

Abstract

Background

Statin treatment in association with physical exercise can substantially reduce mortality in dyslipidaemic individuals. However, the available data to compare the efficacy and safety of statins and exercise combination therapy with statin monotherapy are limited.

Design

Systematic review and meta-analysis.

Methods

We systematically searched PubMed, Embase and the Cochrane Library from database inception until December 2016. We included randomised and non-randomised studies that compared the efficacy and safety of statins and exercise combination therapy with statin monotherapy in patients with dyslipidaemia. Standardised mean differences were calculated and pooled by means of fixed effects models. The risk of bias and heterogeneity among trials was also assessed. Seven articles were assessed in terms of the efficacy of therapy and 13 from the viewpoint of therapeutic safety.

Results

In terms of efficacy, statins and exercise combination decreased the incidence of diabetes mellitus, improved insulin sensitivity and inflammation, but caused no change in lipid profile compared to statins alone. In terms of safety, statins and exercise combination increased peak oxygen uptake (standardised mean difference 1.01, 95% confidence interval 0.46 to 1.57) compared to statins alone. In contrast to statin-induced myopathy, chronic exercise training prior to statin treatment could counteract statin-induced adverse effects in skeletal muscle.

Conclusion

Statins and exercise combination therapy is more effective than statin monotherapy in terms of insulin sensitivity, inflammation and exercise capacity. The small number of studies warrants the need for more randomised controlled trials evaluating the efficacy and safety of combination therapy.

Keywords

Hydroxymethylglutaryl-CoA reductase inhibitors exercise dyslipidemia

Get full access to this article

View all access options for this article.

References

Mihaylova

Emberson

Blackwell

. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (London, England) 2012; 380: 581–590.

Warburton

Nicol

Bredin

. Health benefits of physical activity: the evidence. CMAJ 2006; 174: 801–809.

Booth

Roberts

Laye

. Lack of exercise is a major cause of chronic diseases. Comprehens Physiol 2012; 2: 1143–1211.

Zmuda

Yurgalevitch

Flynn

. Exercise training has little effect on HDL levels and metabolism in men with initially low HDL cholesterol. Atherosclerosis 1998; 137: 215–221.

Physical Activity Guidelines Advisory Committee. Physical Activity Guidelines Advisory Committee report, Washington: Physical Activity Guidelines Advisory Committee, 2008.

Higgins

Altman

Gotzsche

. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928–d5928.

Higgins

Thompson

. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.

Mantel

Haenszel

. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–748.

Egger

Davey Smith

Schneider

. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.

10.

Moher

Liberati

Tetzlaff

. the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336–341.

11.

Kokkinos

Faselis

Myers

. Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study. Lancet 2013; 381: 394–399.

12.

Wittke

. Effect of fluvastatin in combination with moderate endurance training on parameters of lipid metabolism. Sports Med (Auckland, NZ) 1999; 27: 329–335.

13.

Meex

Phielix

Schrauwen-Hinderling

. The use of statins potentiates the insulin-sensitizing effect of exercise training in obese males with and without type 2 diabetes. Clin Sci (London, England) 2010; 119: 293–301.

14.

Konig

Deibert

Winkler

. Association between LDL-cholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease. Exerc Immunol Rev 2005; 11: 97–107.

15.

Radford

DeFina

Barlow

. Effect of fitness on incident diabetes from statin use in primary prevention. Atherosclerosis 2015; 239: 43–49.

16.

Panayiotou

Paschalis

Nikolaidis

. No adverse effects of statins on muscle function and health-related parameters in the elderly: an exercise study. Scand J Med Sci Sports 2013; 23: 556–567.

17.

Coen

Flynn

Markofski

. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population. Metabolism: Clin Exp 2010; 59: 1775–1783.

18.

Parker

Augeri

Capizzi

. Effect of statins on creatine kinase levels before and after a marathon run. Am J Cardiol 2012; 109: 282–287.

19.

Reust

Curry

Guidry

. Lovastatin use and muscle damage in healthy volunteers undergoing eccentric muscle exercise. Western J Med 1991; 154: 198–200.

20.

Thompson

Gadaleta

Yurgalevitch

. Effects of exercise and lovastatin on serum creatine kinase activity. Metabolism: Clin Exp 1991; 40: 1333–1336.

21.

Thompson

Zmuda

Domalik

. Lovastatin increases exercise-induced skeletal muscle injury. Metabolism: Clin Exp 1997; 46: 1206–1210.

22.

Kearns

Bilbie

Clarkson

. The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. Atherosclerosis 2008; 200: 121–125.

23.

Seachrist

Loi

Evans

. Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity. Toxicol Sci 2005; 88: 551–561.

24.

Coen

Flynn

Markofski

. Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage. Metabolism: Clin Exp 2009; 58: 1030–1038.

25.

Meador

Huey

. Statin-associated changes in skeletal muscle function and stress response after novel or accustomed exercise. Muscle Nerve 2011; 44: 882–889.

26.

Bouitbir

Charles

Rasseneur

. Atorvastatin treatment reduces exercise capacities in rats: involvement of mitochondrial impairments and oxidative stress. J Appl Physiol (Bethesda, MD) 2011; 111: 1477–1483.

27.

Mikus

Boyle

Borengasser

. Simvastatin impairs exercise training adaptations. J Am Coll Cardiol 2013; 62: 709–714.

28.

Tani

Nagao

Anazawa

. Coronary plaque regression and lifestyle modification in patients treated with pravastatin – assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol. Circulation J 2010; 74: 954–961.

29.

Thompson

Panza

Zaleski

. Statin-associated side effects. J Am Coll Cardiol 2016; 67: 2395–2410.

30.

Collins

Reith

Emberson

. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet (London, England) 2016; 388: 2532–2561.

31.

Auer

Sinzinger

Franklin

. Muscle- and skeletal-related side-effects of statins: tip of the iceberg? Eur J Prev Cardiol 2016; 23: 88–110.

32.

Deichmann

Lavie

Asher

. The interaction between statins and exercise: mechanisms and strategies to counter the musculoskeletal side effects of this combination therapy. Ochsner J 2015; 15: 429–437.

33.

Bonfim

Oliveira

do Amaral

. Treatment of dyslipidemia with statins and physical exercises: recent findings of skeletal muscle responses. Arquivos brasileiros de cardiologia 2015; 104: 324–331.

34.

Opie

. Exercise-induced myalgia may limit the cardiovascular benefits of statins. Cardiovasc Drugs Ther 2013; 27: 569–572.

35.

Meador

Huey

. Statin-associated myopathy and its exacerbation with exercise. Muscle Nerve 2010; 42: 469–479.

36.

Giuliano

Karahalios

Neil

. The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure – a meta-analysis. Intl J Cardiol 2017; 227: 413–423.